Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Source: SeekingAlpha
2026-02-11 10:00:00 ET
It takes all the running you can do to keep in the same place. If you want to get somewhere else, you must run at least twice as fast!
—Through the Looking-Glass (Lewis Carroll)
Looking Back
About 1.5 years ago, I opened a Long position in Bristol-Myers Squibb Company ( BMY ) and wrote a bullish article called ' Don't Let The Market Fool You .'...
Read the full article on Seeking Alpha
For further details see:
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Takeda Pharmaceutical Company Limited American Depositary Shares
NASDAQ: TAK
TAK Trading
1.14% G/L:
$18.17 Last:
149,407 Volume:
$18.15 Open:
TAK Latest News
March 02, 2026 02:00:00 am
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
February 24, 2026 09:35:00 am
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
TAK Stock Data
$57,107,745,653
3,115,826,299
N/A
157
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
